Naomi Kresge, a senior reporter at Bloomberg, dives into the pharmaceutical industry's rising fears over looming tariff announcements that could impact drug pricing and supply chains. Brendan Murray, a trades expert, shares insights on how these tariffs might reshape the market landscape. They discuss the unfolding uncertainty from the Trump administration's plans and the potential economic ripple effects, from rising costs to shifting global trade dynamics. The conversation sheds light on the nervous atmosphere as businesses brace for impact.
